[Federal Register Volume 84, Number 116 (Monday, June 17, 2019)]
[Notices]
[Page 28075]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-12740]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: The registrant listed below have applied for and been granted 
registration by the Drug Enforcement Administration (DEA) as an 
importer of schedule I controlled substances.

SUPPLEMENTARY INFORMATION: The company listed below applied to be 
registered as an importer of basic class of controlled substances. 
Information on previously published notice is listed in the table 
below. No comments or objections were submitted and no requests for a 
hearing were submitted for this notice.

------------------------------------------------------------------------
              Company                   FR Docket          Published
------------------------------------------------------------------------
Sanyal Biotechnology, LLC.........  84 FR 13953        April 8, 2019.
------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of the listed registrant to 
import the applicable basic class of schedule I controlled substances 
is consistent with the public interest and with United States 
obligations under international treaties, conventions, or protocols in 
effect on May 1, 1971. The DEA investigated the company's maintenance 
of effective controls against diversion by inspecting and testing the 
company's physical security systems, verifying the company's compliance 
with state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer for schedule I controlled substances to the above listed 
company.

    Dated: June 7, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-12740 Filed 6-14-19; 8:45 am]
 BILLING CODE 4410-09-P